California Public Employees Retirement System cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 5.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 113,364 shares of the biotechnology company's stock after selling 6,819 shares during the quarter. California Public Employees Retirement System owned 0.15% of Axon Enterprise worth $67,374,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of AXON. Arrowstreet Capital Limited Partnership boosted its stake in Axon Enterprise by 697.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 7,357 shares of the biotechnology company's stock valued at $4,372,000 after acquiring an additional 6,434 shares during the last quarter. Strategy Asset Managers LLC purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $220,000. Allstate Corp bought a new position in Axon Enterprise during the fourth quarter valued at $1,253,000. Level Four Advisory Services LLC increased its position in Axon Enterprise by 23.3% in the fourth quarter. Level Four Advisory Services LLC now owns 968 shares of the biotechnology company's stock worth $575,000 after buying an additional 183 shares during the last quarter. Finally, Pictet Asset Management Holding SA raised its stake in shares of Axon Enterprise by 3.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 44,934 shares of the biotechnology company's stock valued at $26,705,000 after buying an additional 1,669 shares during the period. 79.08% of the stock is currently owned by institutional investors.
Axon Enterprise Price Performance
Shares of AXON stock traded down $18.73 during trading hours on Thursday, hitting $539.69. 661,869 shares of the company's stock were exchanged, compared to its average volume of 810,044. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a market capitalization of $41.35 billion, a PE ratio of 139.46, a PEG ratio of 5.17 and a beta of 1.13. The business's 50 day simple moving average is $584.52 and its 200-day simple moving average is $552.70. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.
Insider Buying and Selling
In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 6.10% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the company. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price on the stock. Finally, Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.
Get Our Latest Analysis on AXON
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.